Semaglutide AQ -8 MG / PEN -8 MG / 3 ML PEN
Description:
Dosage:
8 MG / PENQuantity:
8 MG / 3 ML PENWeight:
0.00000 KG
ZPHC PHARMA
Zhengzhou Pharmaceutical (ZPHC) is familiar for its stringent quality control standards as well as laboratory-tested preparations, guaranteeing safe and effective medicine and solutions.
Tags :
100% original guarantee
Return within 30days
Free delivery on all orders
🧬 Semaglutide AQ – 8 MG / 3 ML Pen – ZPHC PHARMA
💉 Product Description
Semaglutide is a GLP-1 receptor agonist developed to improve blood sugar regulation and support weight loss. It mimics the natural hormone GLP-1 (Glucagon-Like Peptide-1), which plays a key role in glucose metabolism and appetite control.
This pharmaceutical-grade product by ZPHC PHARMA comes as a ready-to-use aqueous solution in a prefilled pen (AQ), delivering 8 mg of Semaglutide in a 3 ml pen (2.67 mg/ml).
📦 Product Details
| Feature | Description |
|---|---|
| Product Name | Semaglutide AQ |
| Manufacturer | ZPHC PHARMA |
| Concentration | 8 mg / 3 ml (2.67 mg/ml) |
| Form | Liquid Pen (Subcutaneous use) |
| Administration | Once Weekly Injection |
⚙️ Mechanism of Action
Semaglutide works by mimicking the GLP-1 hormone to:
- 🧬 Stimulate insulin secretion in response to elevated glucose
- 🧁 Suppress glucagon (which raises blood sugar)
- 🍽️ Reduce appetite and cravings
- 🔥 Promote fat loss and satiety
- ⏳ Delay gastric emptying, keeping you fuller longer
🎯 Primary Benefits
| Benefit | Description |
|---|---|
| 🔻 Weight Loss | Up to 15–18% body weight reduction |
| 🧪 Blood Sugar Control | Helps manage Type 2 Diabetes |
| 🧠 Appetite Suppression | Reduces cravings and meal volume |
| 🔬 Improved Metabolism | Enhances insulin sensitivity and lipid profile |
⏱️ Recommended Dosing Protocol
Gradual dose escalation helps minimize nausea and improves tolerance.
| Week | Suggested Weekly Dose |
|---|---|
| 1–2 | 0.25 mg / week |
| 3–4 | 0.5 mg / week |
| 5–6 | 1.0 mg / week |
| 7–8 | 1.7 mg / week (optional) |
| Beyond | Up to 2.4 mg / week max |
- Inject once weekly, same day each week
- Subcutaneous injection (abdomen, thigh, or upper arm)
⚠️ Possible Side Effects
| Side Effect | Frequency |
|---|---|
| Nausea | Common (initial weeks) |
| Constipation | Mild to moderate |
| Vomiting or Dizziness | Possible with dose increases |
| Appetite Loss | Desired for fat loss |
Most symptoms fade after the first few weeks of use.
🧊 Storage Guidelines
- Store refrigerated at 2–8°C (36–46°F)
- Do not freeze
- Once opened, keep refrigerated and use within the product’s recommended timeframe
🛑 Precautions
-
Not suitable for individuals with:
- Personal/family history of medullary thyroid carcinoma (MTC)
- History of pancreatitis
- Use with caution if also on insulin or other diabetic medications
✅ Summary
Semaglutide AQ – 8 mg by ZPHC PHARMA is a potent once-weekly injectable GLP-1 agonist ideal for:
- 🔥 Effective fat loss
- 🧠 Controlling appetite and emotional eating
- 🧬 Stabilizing blood sugar levels
- 🩺 Improving overall metabolic health
When combined with the right nutrition and training strategy, it becomes a powerful tool for cutting, body recomposition, or long-term health transformation.
| Brands | ZPHC PHARMA |